BRIEF-M28 Capital Management Lp Reports 8.50% Stake In Adagio Therapeutics Inc, As Of August 17, 2022 - SEC Filing

Reuters2022-08-20

* M28 CAPITAL MANAGEMENT LP REPORTS 8.50% STAKE IN ADAGIO THERAPEUTICS INC, AS OF AUGUST 17, 2022 - SEC FILING

* M28 CAPITAL MANAGEMENT LP HAD EARLIER REPORTED A 5.78% STAKE IN ADAGIO THERAPEUTICS INC, AS OF JUNE 22, 2022

Source text for Eikon: Further company coverage:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2260373725?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-08-20 05:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2260373725","market":"us","top_or_hot":-1,"title":"BRIEF-M28 Capital Management Lp Reports 8.50% Stake In Adagio Therapeutics Inc, As Of August 17, 2022 - SEC Filing","media":"Reuters","content":"<html><body><p><a href=\"https://laohu8.com/S/ADGI\">Adagio Therapeutics</a> Inc   :</p><p>   * M28 CAPITAL MANAGEMENT LP REPORTS 8.50% STAKE IN ADAGIO THERAPEUTICS INC, AS OF AUGUST 17, 2022 - SEC FILING</p><p>   * M28 CAPITAL MANAGEMENT LP HAD EARLIER REPORTED A 5.78% STAKE IN ADAGIO THERAPEUTICS INC, AS OF JUNE 22, 2022</p><p>Source text for Eikon:    Further company coverage:   </p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-M28 Capital Management Lp Reports 8.50% Stake In Adagio Therapeutics Inc, As Of August 17, 2022 - SEC Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-M28 Capital Management Lp Reports 8.50% Stake In Adagio Therapeutics Inc, As Of August 17, 2022 - SEC Filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-20 05:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Adagio Therapeutics Inc   :   * M28 CAPITAL MANAGEMENT LP REPORTS 8.50% STAKE IN ADAGIO THERAPEUTICS INC, AS OF AUGUST 17, 2022 - SEC FILING   * M28 CAPITAL MANAGEMENT LP HAD EARLIER REPORTED A 5.78% ...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CGEM","symbol_name":"Cullinan Therapeutics","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2260373725","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2260373725","pubTimestamp":1660944808,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Adagio Therapeutics Inc   :   * M28 CAPITAL MANAGEMENT LP REPORTS 8.50% STAKE IN ADAGIO THERAPEUTICS","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CGEM":"Cullinan Therapeutics","BK4196":"保健护理服务","BK4082":"医疗保健设备","LABP":"Landos Biopharma, Inc.","BK4007":"制药","ONTF":"ON24, Inc.","BK4539":"次新股","APR":"Apria, Inc.","SANA":"Sana Biotechnology, Inc.","LHDX":"Lucira Health, Inc.","BK4139":"生物科技","BK4023":"应用软件"},"translate_title":"简报-M28 Capital Management Lp报告称，截至2022年8月17日，该公司持有慢板治疗公司8.50%的股份--美国证券交易委员会提交的文件","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADGI":1,"APR":1,"CGEM":1,"LABP":1,"LHDX":1,"ONTF":1,"SANA":1},"content_text":"Adagio Therapeutics Inc   :   * M28 CAPITAL MANAGEMENT LP REPORTS 8.50% STAKE IN ADAGIO THERAPEUTICS INC, AS OF AUGUST 17, 2022 - SEC FILING   * M28 CAPITAL MANAGEMENT LP HAD EARLIER REPORTED A 5.78% STAKE IN ADAGIO THERAPEUTICS INC, AS OF JUNE 22, 2022Source text for Eikon:    Further company coverage:","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2260373725"}